|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense), net | |||||
| Other income (expense) | |||||
| Gain on settlement | |||||
| Financing expense | |||||
| Change in fair value of warrant liability | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Unrealized loss on marketable securities | |||||
| Unrealized foreign currency translation adjustment | |||||
| Total comprehensive loss | |||||
| Deemed dividend attributable to Series J Convertible Preferred Stock | |||||
| Dividend on Series J Convertible Preferred Stock | |||||
| Net loss attributable to common stockholders | |||||
| Basic loss per share (in Dollars per share) | |||||
| Diluted loss per share (in Dollars per share) | |||||
| Weighted average shares outstanding - basic (in Shares) | |||||
| Weighted average shares outstanding - diluted (in Shares) | |||||
Loading...